Marshall Wace’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.3M | Buy |
422,715
+856
| +0.2% | +$37K | 0.02% | 561 |
|
|
2025
Q1 | $14.6M | Sell |
421,859
-406,099
| -49% | -$14M | 0.02% | 570 |
|
|
2024
Q4 | $22.7M | Sell |
827,958
-5,278
| -0.6% | -$145K | 0.03% | 459 |
|
|
2024
Q3 | $21.2M | Buy |
833,236
+802,387
| +2,601% | +$20.4M | 0.03% | 449 |
|
|
2024
Q2 | $781K | Buy |
+30,849
| New | +$781K | ﹤0.01% | 1624 |
|
|
2024
Q1 | – | Sell |
-37,897
| Closed | -$1.53M | – | 2122 |
|
|
2023
Q4 | $1.53M | Sell |
37,897
-125,019
| -77% | -$5.05M | ﹤0.01% | 1104 |
|
|
2023
Q3 | $4.3M | Buy |
+162,916
| New | +$4.3M | 0.01% | 826 |
|
|
2023
Q2 | – | Sell |
-1,084,595
| Closed | -$18M | – | 2014 |
|
|
2023
Q1 | $18M | Buy |
+1,084,595
| New | +$18M | 0.04% | 434 |
|
|
2022
Q4 | – | Sell |
-71,245
| Closed | -$708K | – | 2329 |
|
|
2022
Q3 | $708K | Buy |
+71,245
| New | +$708K | ﹤0.01% | 1924 |
|
|
2022
Q1 | – | Sell |
-290,362
| Closed | -$4.84M | – | 2625 |
|
|
2021
Q4 | $4.84M | Buy |
290,362
+274,843
| +1,771% | +$4.58M | 0.01% | 1213 |
|
|
2021
Q3 | $727K | Buy |
+15,519
| New | +$727K | ﹤0.01% | 1705 |
|
|
2021
Q2 | – | Sell |
-75,995
| Closed | -$4.68M | – | 2111 |
|
|
2021
Q1 | $4.68M | Buy |
+75,995
| New | +$4.68M | 0.02% | 791 |
|